And a crap load more IP on chondrocyte and tenocyte stem cells and trial data and a better collagen matrix product already being sold by big US Pharma. I shake my head at the market sometimes. There are dozens of firms out there marketing similar inferior collagen scaffolds. Hope Zimmer's lawyers have done their homework on the IP!
Its funny, I thought this would have buoyed the OCC share price, big Pharma again looking at the very area CelGro technology was in part developed for (the main reason because OCC could not find a good enough collagen matrix to hold chondrocyte cells in place for ACI, so Zheng developed his own). Instead it gets sold down on SP500/ASX200 gains? Strange.
Stem Cell Therapy advancements, page-384
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.5¢ | $49.66K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20305 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 77938 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |